1 ml contains active substances :

Tylosin tartrate – 50 mg.  

Tylosin, derived from Streptomyces fradiae, primarily comprises tylosin A and exhibits efficacy against a wide range of gram-positive and some gram-negative microorganisms, including Streptococcus spp., Staphylococcus spp., and others. It inhibits protein synthesis via irreversible binding to bacterial ribosomal subunits, exerting a bacteriostatic effect.

Tylosin is indicated for treating various conditions in cattle, sheep, goats, pigs, dogs, and cats caused by tylosin-sensitive microorganisms. These include bronchopneumonia, mastitis, otitis, and others.

Administered intramuscularly once daily at the following doses:

  • Cattle: 1-2 ml per 10 kg of body weight
  • Sheep, goats: 1.0-2.0 ml per 10 kg of body weight
  • Pigs: 2.0 ml per 10 kg of body weight
  • Dogs, cats: 1.0-2.0 ml per 10 kg body weight. Discontinue treatment within 24 hours after symptoms resolve or within 5 days of application. Divide doses exceeding the recommended amount and administer at multiple sites.

Avoid use in animals hypersensitive to tylosin or in the first week of life. Do not combine with penicillins, cephalosporins, or lincomycin due to diminished efficacy. Not for use in horses, rabbits, guinea pigs, or hamsters.

Meat consumption is permissible 8 days post-treatment, and milk consumption is allowed after 4 days. Dispose of meat and milk from unproductive animals per veterinary advice.

Available in 50 ml and 100 ml glass vials.

Store in a dry, dark place at temperatures between 5°C to 25°C, out of reach of children. Use within 28 days of first opening under proper storage conditions.